Followers | 9 |
Posts | 740 |
Boards Moderated | 0 |
Alias Born | 10/06/2010 |
Thursday, January 26, 2012 5:12:22 PM
KBLB is doing everything to further it's commercially viable product. It just hasn't gone commercial yet.
What is KBLB worth just on it's rights, agreements and trademarks? It has the sole right to commercialize this product. What is that worth? I guess about 8 cents right now. But really, as the science continues, as they get to a purer form of spider silk or develop the next groundbreaking hybrid material, how much is just the right to commercialize that? That alone gives value to the company. The doubt that there isnt a product has cleared. It was cleared at the Notre Dame PC but now that PNAS has published the findings it is a great stamp of certainty.
There is a product. How much do they charge, how do they license it, should they give exclusivity, when will we hear about it? These are the only questions on my mind.
KBLB DOES NOT have to first hand commercialize the spidersilk,
It DOES have the right to pick who can. There are plenty of companies who can. You might not like Kim Thompson, but you might like who he picks.
He's had a knack of associating with the right people to get the real work done.
We'll see.
GO KBLB.
Everything I say is my own opinion and should not be taken as direct investment advice. Do your own DD and make your own decisions.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM